Organon & Co.

Healthcare

NYSE:OGN · New York Stock Exchange

Market Cap $3.54B Beta 1.54 P/E (TTM) 14.2

$13.44 -0.07%

-$0.01 today

52W Low $5.69High $13.49

Vol 1.81M · Avg 8.62M

EPS (TTM)$0.94

Div Yield0.60%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+35.08%

Period High

$13.46

Period Low

$5.69

Latest

$13.44

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Guardian Pharmacy Services, Inc.

NYSE:GRDN

$2.73B

Avadel Pharmaceuticals plc

AVDL

$2.12B

Select Medical Holdings Corporation

NYSE:SEM

$2.07B

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

$2.03B

Pediatrix Medical Group, Inc.

NYSE:MD

$2.00B

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

$1.99B

Nuvation Bio Inc.

NYSE:NUVB

$1.71B

Alvotech

NASDAQ:ALVO

$1.30B

Phibro Animal Health Corporation

NASDAQ:PAHC

$1.28B

Tilray Brands, Inc.

NASDAQ:TLRY

$595.63M

What is the latest OGN filing?

The latest filing shown is DEFA14A dated Jun 11, 2026.

How many recent filings does OGN have?

Intrinsic Alpha currently shows 20 recent filings for OGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.